טוען...

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review

Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as obesity and diabetes mellitus, leading to increased mortality. Antipsychotics (APs), which are the mainstay in the tre...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Raghunath Singh, Nicolette Stogios, Emily Smith, Jiwon Lee, Kateryna Maksyutynsk, Emily Au, David C. Wright, Giada De Palma, Ariel Graff-Guerrero, Philip Gerretsen, Daniel J. Müller, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal
פורמט: Artigo
שפה:Inglês
יצא לאור: SAGE Publishing 2022-05-01
סדרה:Therapeutic Advances in Psychopharmacology
גישה מקוונת:https://doi.org/10.1177/20451253221096525
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!